Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,399 | 83,389 | 105,017 | 203,234 | 129,975 |
| Marketable Securities | 163,322 | 180,743 | 193,615 | 149,884 | 133,098 |
| Receivables | 12,881 | 11,062 | 9,581 | 9,281 | 7,862 |
| Inventories | 2,644 | 2,011 | 1,652 | 970 | 346 |
| TOTAL | $276,531 | $285,447 | $317,836 | $370,920 | $278,570 |
| Non-Current Assets | |||||
| PPE Net | 2,219 | 2,357 | 2,592 | 2,814 | 3,046 |
| Investments And Advances | 24,215 | 39,371 | 48,856 | 31,373 | 2,016 |
| Other Non-Current Assets | 10,085 | 10,412 | 10,727 | 11,034 | 11,331 |
| TOTAL | $36,519 | $52,140 | $62,175 | $45,221 | $16,393 |
| Total Assets | $313,050 | $337,587 | $380,011 | $416,141 | $294,963 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,450 | 2,422 | 1,888 | 1,694 | 985 |
| Accrued Expenses | 52,930 | 46,591 | 45,979 | 43,783 | 40,878 |
| Other current liabilities | 609 | 1,473 | 628 | 1,224 | 500 |
| TOTAL | $60,203 | $52,630 | $50,570 | $49,699 | $46,350 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 297 | 297 | 297 | 1,287 | 2,341 |
| Other Non-Current Liabilities | 202,301 | 201,187 | 199,642 | 198,103 | 196,647 |
| TOTAL | $202,301 | $201,187 | $199,642 | $200,295 | $198,839 |
| Total Liabilities | $262,504 | $253,817 | $250,212 | $249,994 | $245,189 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,978 | 4,909 | 4,901 | 4,877 | 4,372 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -1,069,611 | -1,026,190 | -972,695 | -926,269 | -873,338 |
| Other shareholders' equity | 518 | 603 | 891 | -420 | -37 |
| TOTAL | $50,546 | $83,770 | $129,799 | $166,147 | $49,774 |
| Total Liabilities And Equity | $313,050 | $337,587 | $380,011 | $416,141 | $294,963 |